Prophy Med AB
Records under this name other than patents Prophy Med AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Prophy Med AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,629,123 | Use of dextran sulfate Formerly held Lapsed on the fee record Ended Jan 14, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 14, 2026 | USPTO record |
| US 8,906,884 | Method of treating graft-rejection using dextran sulfate Formerly held Term ended Term ended Aug 17, 2025 · USPTO record | Term ended | Term ended Aug 17, 2025 | USPTO record |
| US 8,784,845 | Selective chemokine modulation Lapsed on the fee record Ended Jul 22, 2022 · USPTO record | Lapsed on the fee record | Ended Jul 22, 2022 | USPTO record |
| US 9,656,015 | Selective chemokine modulation Lapsed on the fee record Ended May 23, 2021 · USPTO record | Lapsed on the fee record | Ended May 23, 2021 | USPTO record |
| US 9,649,426 | Selective chemokine modulation Lapsed on the fee record Ended May 16, 2021 · USPTO record | Lapsed on the fee record | Ended May 16, 2021 | USPTO record |